These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 25902062

  • 1. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S, Rentsch P, Li KM, Vissel B.
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease.
    Yu H, Liu X, Chen B, Vickstrom CR, Friedman V, Kelly TJ, Bai X, Zhao L, Hillard CJ, Liu QS.
    Cells; 2021 Dec 16; 10(12):. PubMed ID: 34944056
    [Abstract] [Full Text] [Related]

  • 4. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S, Mishra A, Mohanbhai SJ, Tiwari V, Chaturvedi RK, Khurana S, Shukla S.
    Free Radic Biol Med; 2018 Dec 16; 129():73-87. PubMed ID: 30176346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model.
    Ren X, Zhang T, Gong X, Hu G, Ding W, Wang X.
    Exp Neurol; 2013 Oct 16; 248():148-56. PubMed ID: 23764500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Sleeman IJ, Boshoff EL, Duty S.
    Neuropharmacology; 2012 Dec 16; 63(7):1268-77. PubMed ID: 22971544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 16; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S, Xu Y, Chen G, Ma K, Han C, Guo Z, Zhang Z, Ye K, Cao X.
    Neuropharmacology; 2015 Dec 16; 99():448-58. PubMed ID: 26282118
    [Abstract] [Full Text] [Related]

  • 17. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
    Hong J, Sha S, Zhou L, Wang C, Yin J, Chen L.
    Cell Death Dis; 2015 Jul 23; 6(7):e1832. PubMed ID: 26203861
    [Abstract] [Full Text] [Related]

  • 18. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR, Moon LDF, Duty S.
    BMC Neurosci; 2019 Dec 20; 20(1):61. PubMed ID: 31862005
    [Abstract] [Full Text] [Related]

  • 19. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS, Ladd FVL, Ladd AABL, Moreira AL, Boeira SP, Cattelan Souza L.
    Metab Brain Dis; 2021 Jan 20; 36(1):153-167. PubMed ID: 33057922
    [Abstract] [Full Text] [Related]

  • 20. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y, Lin S, Wright C, Shen J, Carter K, Bhatt A, Fan LW.
    Neuroscience; 2016 Mar 24; 318():157-65. PubMed ID: 26777890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.